Event info
Date:17 Jun
Time:16:00 - 18:00
Contact person
Nicole Mastrell

Nicole Mastrell

Event Manager & PA to CEO


+45 6141 8634

PEG Virtual Symposium

Enabling Technologies and Today‘s Trends

You are cordially invited to participate in MilliporeSigma‘s virtual 2021 PEG Symposium.

This technical symposium is a unique opportunity to discover enabling technologies and today‘s trends in the broad field of pharmaceutical PEG applications, development, and processing.

  • Industry experts will be presenting the latest progress in activated PEGs and conjugation.
  • Learn about next generation of protein PEGylation and PEG analytics.
  • Get perspectives on regulatory aspects for activated PEGs in pharmaceutical applications.
  • Discuss and tackle today’s PEG challenges with your peers.


Date: June 17th, 2021
Time: 16:00 – 18:00 CEST/10:00 AM – 12:00 PM EST
Venue: Online

The event is free of charge, though registration is required.
Attendance to the PEG Symposium is limited and available to pharma/biopharma manufacturers only. The offer does not extend to any company that provides products or services to the pharma/biopharma industry. MilliporeSigma reserves the right to revoke or refuse participation at any times.




Lisa McDermott, Merck KGaA,
Darmstadt, Germany


Speakers & Presentations:

  • Lars Albermann, Ph. D. Merck KGaA, Darmstadt, Germany
    Regulatory Requirements of Activated PEGs in Pharmaceutical Products


  • Sukumar Sakamuri, Ph. D. Ambrx
    Engineered Precision Biologics: Designing Next Generation PEGylated Proteins Using Ambrx Site-specific Conjugation Technology


  • Tobias Haag, Ph. D. Merck KGaA, Darmstadt, Germany
    Functionalized PEGs: Quality Attributes and Analytical Method Development


  • Marco Passafaro, Ph. D. Merck KGaA, Darmstadt, Germany
    Applications of Monodisperse PEGs


Organized by:


Merck logo